Trailblazing Genomics

2023-10-11T15:12:57+01:0011 October 2023|

As a top UK innovator, the Sanger Institute’s work is foundational to many. We enable partners to apply our science and advance it to develop products, services and therapeutics - solving real-world problems

From genomes to medicines: an interview with Ian Dunham

2022-12-01T12:44:55+00:0019 October 2022|

Ian Dunham has been a pillar of Open Targets since its inception. Helena Cornu sat down with him to understand how his career led him from the Human Genome Project to Director of Open Targets, and what he envisions for the future of the consortium.‌